The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | BBG001V0GG18 | 12,958,274 | 2,377,665 | SH | SOLE | 2,377,665 | 0 | 0 | ||
AKOYA BIOSCIENCES INC | COM | 00974H104 | BBG00JX4LRX4 | 21,844,700 | 4,697,785 | SH | SOLE | 4,697,785 | 0 | 0 | ||
GUARDANT HEALTH INC | COM | 40131M109 | BBG006D97VZ8 | 20,038,033 | 676,047 | SH | SOLE | 676,047 | 0 | 0 | ||
MAXCYTE INC | COM | 57777K106 | BBG00CFTQNG7 | 5,881,200 | 1,885,000 | SH | SOLE | 1,885,000 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | BBG001TG36G6 | 6,453,253 | 3,751,891 | SH | SOLE | 3,751,891 | 0 | 0 | ||
NATERA INC | COM | 632307104 | BBG001V0FSF8 | 35,286,543 | 797,436 | SH | SOLE | 797,436 | 0 | 0 | ||
SONENDO INC | COM | 835431107 | BBG002082QS7 | 3,463,093 | 4,643,461 | SH | SOLE | 4,643,461 | 0 | 0 |